Description
This webinar explores how Blow-Fill-Seal (BFS) technology can accelerate the development and delivery of injectable drugs and vaccines — from early formulation to large-scale distribution. By combining unmatched sterility, flexible formats like Euroject®, and high cold chain resilience, BFS offers a compelling alternative to pre-filled syringes and multidose vials. You’ll discover Unither’s co-development approach, how it supports biologics and field-ready devices, and what performance data says about BFS under extreme conditions.
Learning outcomes:
- Understand BFS technology in the context of global vaccine and biologics needs;
- Learn how BFS compares to other delivery formats (PFS, multidose) across critical criteria;
- Explore real-world BFS applications and data on temperature-sensitive biologics;
- Discover the Euroject® platform and its potential for LMICs;
- Learn how Unither supports faster, safer, and leaner product journeys.
